Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fry

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Scientific Reports|December 18, 2019
Ten-Second Electrophysiology: Evaluation of the 3DEP Platform for high-speed, high-accuracy cell analysisKai F Hoettges, Erin A Henslee, Ruth M Torcal Serrano, et al.
Journal of Racial and Ethnic Health Disparities|June 18, 2025
Health Status And Delays In Referral-To-Treatment Waiting Times for Elective Admissions of Adults From Deprived Areas And Ethnic Minority Backgrounds: A Study of Healthcare InequalitiesDavid Fluck, Emma Jackson, Ana Llamas-Montoya, et al.
Endocrine-Related Cancer|March 12, 2015
Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancerRosalinda M Savoy, Liqun Chen, Salma Siddiqui, et al.
Protein Science : a Publication of the Protein Society|December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closureKenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2017
Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancerCunxi Li, Bhuminder Singh, Ramona Graves-Deal, et al.
Biochemistry|June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitorsKenton L Longenecker, Kent D Stewart, David J Madar, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Journal of Medicinal Chemistry|March 27, 2010
Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitorThomas D Penning, Gui-Dong Zhu, Jianchun Gong, et al.
Bioorganic & Medicinal Chemistry|June 11, 2008
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancerThomas D Penning, Gui-Dong Zhu, Viraj B Gandhi, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Scientific Reports|December 18, 2019
Ten-Second Electrophysiology: Evaluation of the 3DEP Platform for high-speed, high-accuracy cell analysisKai F Hoettges, Erin A Henslee, Ruth M Torcal Serrano, et al.
Journal of Racial and Ethnic Health Disparities|June 18, 2025
Health Status And Delays In Referral-To-Treatment Waiting Times for Elective Admissions of Adults From Deprived Areas And Ethnic Minority Backgrounds: A Study of Healthcare InequalitiesDavid Fluck, Emma Jackson, Ana Llamas-Montoya, et al.
Endocrine-Related Cancer|March 12, 2015
Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancerRosalinda M Savoy, Liqun Chen, Salma Siddiqui, et al.
Protein Science : a Publication of the Protein Society|December 3, 2005
Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closureKenton L Longenecker, Geoffrey F Stamper, Philip J Hajduk, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2017
Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancerCunxi Li, Bhuminder Singh, Ramona Graves-Deal, et al.
Biochemistry|June 14, 2006
Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitorsKenton L Longenecker, Kent D Stewart, David J Madar, et al.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitorsHongyu Zhao, Michael D Serby, Zhili Xin, et al.
Journal of Medicinal Chemistry|March 27, 2010
Optimization of phenyl-substituted benzimidazole carboxamide poly(ADP-ribose) polymerase inhibitors: identification of (S)-2-(2-fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a highly potent and efficacious inhibitorThomas D Penning, Gui-Dong Zhu, Jianchun Gong, et al.
Bioorganic & Medicinal Chemistry|June 11, 2008
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancerThomas D Penning, Gui-Dong Zhu, Viraj B Gandhi, et al.
Pageof 31